Issued Patents All Time
Showing 25 most recent of 58 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12414952 | Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use | Zachary G. Brill, Amjad Ali, Jared N. Cumming, Duane DeMong, Qiaolin Deng +10 more | 2025-09-16 |
| 12371434 | MLL1 inhibitors and anti-cancer agents | Zhenting GAO, Haibing GUO, Ming Li, Chunliang Lu, Zhuming SUN +1 more | 2025-07-29 |
| 12291688 | Silicon-containing compounds for lubricants | Sheng Jiang, Ashutosh Gupta | 2025-05-06 |
| 12275729 | Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | Yongqi Deng, Abdelghani Achab, David Jonathan Bennett, Indu T. Bharathan, Xavier Fradera +8 more | 2025-04-15 |
| 12263171 | 7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use | Yonglian Zhang, Amjad Ali, Jared N. Cumming, Duane DeMong, Qiaolin Deng +10 more | 2025-04-01 |
| 12060357 | 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use | Matthew A. Larsen, Amjad Ali, Jared N. Cumming, Duane DeMong, Qiaolin Deng +11 more | 2024-08-13 |
| 11319283 | Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | Meredeth A. McGowan, Abdelghani Achab, Xavier Fradera, Yongxin Han, Derun Li +6 more | 2022-05-03 |
| 11312719 | 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use | Matthew A. Larsen, Amjad Ali, Jared N. Cumming, Duane DeMong, Qiaolin Deng +11 more | 2022-04-26 |
| 11111232 | Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | Catherine White, Abdelghani Achab, Indu T. Bharathan, Xavier Fradera, Yongxin Han +7 more | 2021-09-07 |
| 11096930 | Substituted imidazopyridine compounds as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan-2,3-dioxygenase | Phillip M. Cowley, Meredeth A. McGowan, Thomas J. Brown, Yongxin Han, Qinglin Pu +3 more | 2021-08-24 |
| 11053243 | Inhibitors of hepatitis C virus replication | Craig A. Coburn, Steven W. Ludmerer, Hao Wu, Richard Soil, Bin Zhong +1 more | 2021-07-06 |
| 11034661 | Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors | Liangqin Guo, Yongxin Han, Shuwen He, Joseph A. Kozlowski, Ravi Nargund +6 more | 2021-06-15 |
| 10995085 | Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | Yongxin Han, Abdelghani Achab, Yongqi Deng, Xavier Fradera, Craig R. Gibeau +8 more | 2021-05-04 |
| 10988487 | Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | Abdelghani Achab, Purakkattle Biju, Timothy A. Cernak, Yongqi Deng, Xavier Fradera +10 more | 2021-04-27 |
| 10927086 | Substituted sulfoximine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | Dane Clausen, Liangqin Guo, Yongxin Han, Shuwen He, Joseph A. Kozlowski +4 more | 2021-02-23 |
| 10745364 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more | 2020-08-18 |
| 10689369 | Substituted indazole compounds as RORgammaT inhibitors and uses thereof | Blair T. Lapointe, Peter H. Fuller, Hakan Gunaydin, Mark E. Scott, B. Wesley Trotter +1 more | 2020-06-23 |
| 10647705 | Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | Yongxin Han, Abdelghani Achab, Yongqi Deng, Xavier Fradera, Craig R. Gibeau +8 more | 2020-05-12 |
| 10584121 | Heteroaryl substituted benzoic acids as RORgammaT inhibitors and uses thereof | Hongjun Zhang, Kenneth J. Barr, Blair T. Lapointe, Hakan Gunaydin, B. Wesley Trotter | 2020-03-10 |
| 10538497 | Compounds as indoleamine 2,3-dioxygenase inhibitors | Yongxin Han, Abdelghani Achab, Purakkattle Biju, Yongqi Deng, Xavier Fradera +9 more | 2020-01-21 |
| 10344000 | Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof | Blair T. Lapointe, Peter H. Fuller, Hakan Gunaydin, Danielle F. Molinari, Qinglin Pu +3 more | 2019-07-09 |
| 10287272 | Substituted indazole compounds as RORgammaT inhibitors and uses thereof | Blair T. Lapointe, Peter H. Fuller, Hakan Gunaydin, Mark E. Scott, B. Wesley Trotter +1 more | 2019-05-14 |
| 10221146 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more | 2019-03-05 |
| 10221142 | Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof | Blair T. Lapointe, Peter H. Fuller, Hakan Gunaydin, Nunzio Sciammetta, Benjamin Wesley Trotter +5 more | 2019-03-05 |
| 9938299 | Glycosidase inhibitors and uses thereof | Harold G. Selnick, Ernest J. McEachern, Ramesh Kaul, Zhongyong Wei, Yaode Wang +1 more | 2018-04-10 |